OMERS Administration Corp’s Aspire Biopharma Warrant ASBPW Stock Holding History

OMERS Administration Corp’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513	Hold	25,000	–	–	﹤0.01%	903
2026 Q1	$415	Hold	25,000	–	–	﹤0.01%	1093
2025 Q4	$412	Hold	25,000	–	–	﹤0.01%	1024
2025 Q3	$747	Hold	25,000	–	–	﹤0.01%	1128
2025 Q2	$1.12K	Hold	25,000	–	–	﹤0.01%	851
2025 Q1	$1.82K	Hold	25,000	–	–	﹤0.01%	1010
2024 Q4	$1.19K	Hold	25,000	–	–	﹤0.01%	945
2024 Q3	$1.06K	Hold	25,000	–	–	﹤0.01%	868
2024 Q2	$905	Hold	25,000	–	–	﹤0.01%	1013
2024 Q1	$752	Hold	25,000	–	–	﹤0.01%	439
2023 Q4	$1.5K	Hold	25,000	–	–	﹤0.01%	252
2023 Q3	$1.25K	Hold	25,000	–	–	﹤0.01%	203
2023 Q2	$1.37K	Hold	25,000	–	–	﹤0.01%	195
2023 Q1	$1.04K	Hold	25,000	–	–	﹤0.01%	275
2022 Q4	$2K	Buy	+25,000	New	+$1.68K	﹤0.01%	256

Other funds holding ASBPW

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

OMERS Administration Corp's ASBPW Position: Q2 2026 in Review

OMERS Administration Corp held its Aspire Biopharma Warrant (ASBPW) position steady in Q2 2026 at 25,000 shares worth $513. The position accounts for ﹤0.01% of the portfolio, ranked #903.

OMERS Administration Corp first reported a position in ASBPW in Q4 2022 and has held it in 15 quarters since. The position peaked at $2K in Q4 2022. 27 funds tracked by Wall St. Rank hold ASBPW as of Q2 2026.

OMERS Administration Corp held 25,000 shares of Aspire Biopharma Warrant worth $513 as of Q2 2026.
OMERS Administration Corp left its Aspire Biopharma Warrant share count unchanged in Q2 2026.
Aspire Biopharma Warrant made up ﹤0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #903 holding.
OMERS Administration Corp first reported a position in Aspire Biopharma Warrant in Q4 2022 and has held it in 15 quarters since.
OMERS Administration Corp's Aspire Biopharma Warrant position peaked at $2K in Q4 2022.
27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.